Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03477643 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT03477643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03477643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Completed
Start date
April 27, 2018
Completion date
July 14, 2020
Enrollment
110 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed and refractory multiple myeloma